FDA is making every GLP-1 carry a new eye risk warning, and a New York settlement spells out that its ghost network fix stops at the edge of self-funded ERISA plans. Both land on work you already own.
Share

Newsletter

Get The MOC Brief in your inbox

Twice-weekly healthcare policy analysis for self-funded professionals and healthcare leaders committed to eliminating waste and optimizing care delivery.

Newsletter Form